Intra-Cellular price target raised to $81 from $79 at JPMorgan
PremiumThe FlyIntra-Cellular price target raised to $81 from $79 at JPMorgan
2M ago
Intra-Cellular price target raised to $130 from $120 at Cantor Fitzgerald
Premium
The Fly
Intra-Cellular price target raised to $130 from $120 at Cantor Fitzgerald
2M ago
Intra-Cellular price target lowered to $74 from $77 at Goldman Sachs
Premium
The Fly
Intra-Cellular price target lowered to $74 from $77 at Goldman Sachs
2M ago
Is ITCI a Buy, Before Earnings?
PremiumPre-EarningsIs ITCI a Buy, Before Earnings?
2M ago
Intra-Cellular price target raised to $100 from $94 at Needham
Premium
The Fly
Intra-Cellular price target raised to $100 from $94 at Needham
3M ago
Intra-Cellular downgraded to Neutral from Buy at UBS
Premium
The Fly
Intra-Cellular downgraded to Neutral from Buy at UBS
4M ago
Intra-Cellular price target raised to $92 from $91 at BofA
PremiumThe FlyIntra-Cellular price target raised to $92 from $91 at BofA
4M ago
Intra-Cellular announces results for lumateperone as adjunctive therapy in MDD
Premium
The Fly
Intra-Cellular announces results for lumateperone as adjunctive therapy in MDD
4M ago
Intra-Cellular price target raised to $78 from $75 at JPMorgan
Premium
The Fly
Intra-Cellular price target raised to $78 from $75 at JPMorgan
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100